Dietary lipids and intestinal inflammatory disease

Journal of Pediatrics

Volumn 149, Issue 5 SUPPL., 2006, Pages

  Innis, Sheila M ^a   Pinsk, Vered ^a   Jacobson, Kevan ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

LINOLEIC ACID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; COLITIS; CROHN DISEASE; DIET SUPPLEMENTATION; DIETARY INTAKE; ENTERITIS; FAT INTAKE; FATTY ACID METABOLISM; FOOD COMPOSITION; FOOD INTAKE; GENE EXPRESSION; GENETIC PREDISPOSITION; HUMAN; INFLAMMATION; MILK; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STATISTICAL ANALYSIS;

EID: 33747808084     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2006.06.058     Document Type: Article

References (74)

1. Cosgrove M., Al-Atia R.F., and Jenkins H.R. The epidemiology of paediatric inflammatory bowel disease. Arch Dis Child 74 (1996) 460-461
2. Macdonald T.T., and Monteleone G. Immunity, inflammation, and allergy in the gut. Science 307 (2005) 1920-1925
3. Fiocchi C. Inflammatory bowel disease. etiology and pathogenesis. Gastroenterology 115 (1998) 182-205
4. Sartor R.B. Pathogenesis and immune mechanisms of chronic inflammatory bowel diseases. Am J Gastoenterol 92 (1997) 55-119
5. Gustot T., Lemmers A., Louis E., Nicoise C., Quertinmont E., Belaiche J., et al. Profile of soluble cytokine receptors in Crohn's disease. Gut 54 (2005) 488-495
6. Katz J.A., Itoh J., and Fiocchi C. Pathogenesis of inflammatory bowel disease. Curr Opin Gastroenterol 15 (1999) 291-297
7. Lih-Brody L., Powell S.R., Collier K.P., Reddy G.M., Cerchia R., Kahn E., et al. Increased oxidative stress and decreased antioxidant defenses in mucosa of inflammatory bowel disease. Digest Dis Sci 41 (1996) 2078-2086
8. Podolsky D.K., and Fiocchi C. Cytokines, chemokines, growth factors, eicosanoids and other bioactive molecules in inflammatory bowel disease. In: Kirsner J.B. (Ed). Inflammatory bowel disease (2000), WB Saunders, Philadelphia 191-207
9. Koutrobakis I., Manousos O.N., Meuwissen S.G., and Pena A.S. Environmental risk factors in inflammatory bowel disease. Hepatogastroenterology 43 (1996) 381-393
10. Armitage E., Drummond H.E., Wilson D.C., and Ghosh S. Increasing incidence of both juvenile-onset Crohn's disease and ulcerative colitis in Scotland. Eur J Gastroenterol Hepatol 13 (2001) 1439-1447
11. Hassan K., Cowan F.J., and Jenkins H.R. The incidence of childhood inflammatory disease in Wales. Eur J Pediatr 159 (2000) 261-263
12. Linberg E., Lindquist B., Holmquist L., and Hildebrand H. Inflammatory bowel disease in children and adolescents in Sweden, 1984-1995. J Pediatr Gastroenterol Nutr 30 (2000) 259-264
13. Pinsk V., Lemberg D.A., Leonor R., Barker C., Schreiber R., Israel D., et al. Pediatric inflammatory bowel disease. the British Columbia experience. J Pediatr Gastroenterol Nutr 41 (2005) 545
14. Carr I., and Mayberry J.F. The effects of migration on ulcerative colitis. a three-year prospective study among Europeans and first- and second- generation South Asians in Leicester (1991-1994). Am J Gastroenterol 94 (1999) 2918-2922
15. Pinsk V., Lemberg D.A., Schreiber R., Barker C., Israel D., and Jacobson K. The changing pattern of pediatric IBD at British Columbia Children's Hospital. J Pediatr Gastroenterol Nutr 41 (2005) 545
16. Calder P.C. N-3 Polyunsaturated fatty acids and inflammation. from molecular biology to clinic 38 (2003) 343-352
17. Gil A. Polyunsaturated fatty acids and inflammatory disease. Biomed Pharmacother 56 (2002) 388-396
18. Gewirtz A.T., Neish A.S., and Madara J.L. Mechanisms of active intestinal inflammation and potential down-regulation via lipoxins. Adv Exp Med Biol 507 (2002) 229-236
19. Levy B.D., Clish C.B., Schmidt B., Gronert K., and Serhan C.N. Lipid mediator class switching during acute inflammation. signals in resolution. Nat Immunol 2 (2001) 612-619
20. Vachier I., Chanez P., Bonnans C., Godard P., Bousquet J., and Chavis C. Endogenous anti-inflammatory mediators from arachidonate in human neutrophils. Biochim Biopsy Res Commun 290 (2002) 219-224
21. Serhan C.N. Novel eicosanoid and docosanoid mediators. resolvins, docosatrienes and resolvins. Curr Opin Clin Nutr Metal Care 8 (2005) 115-121
22. Jia O., Zhou H.R., Bennink M., and Peska J.J. Docosahexaenoic acid attenuates mycotoxin-induced immunoglobulin a nephropathy, interleukin-6 transcription, and mitogen-activated protein kinase phosphorylation in mice. J Nutr 134 (2004) 3343-3349
23. Denys A., Hichami A., and Khan N.A. Eicosapentaenoic acid and docosahexaenoic acid modulate MAP kinase enzyme activity in human T-cells. Mol Cell Biochem 232 (2002) 143-148
24. Novak T.E., Babcock T.A., Jho D.H., Helton W.S., and Espat N.J. NF-kappa B inhibition by omega-3 fatty acids modulates LPS-stimulated macrophage TNF-alpha transcription. Am J Physiol 284 (2003) L84-L89
25. Komatsu W., Ishihara K., Murata M., Saito H., and Shinohara K. Docosahexaenoic acid suppresses nitric oxide production and inducible nitric oxide synthase expression in interferon-gamma plus lipopolysaccharide-stimulated murine macrophages by inhibiting the oxidative stress. Free Radic Biol Med 34 (2003) 1006-1016
26. Mori T.A., and Beilin L.J. Omega-3 fatty acids and inflammation. Curr Atheroscler Rep 6 (2004) 461-467
27. Shimizu T., Fujii T., Suzuki R., Igarashi J., Ohtsuka Y., Nagata S., et al. Effects of highly purified eicosapentaenoic acid on erythrocyte fatty acid composition and leukocyte and colonic mucosa leukotriene B4 production in children with ulcerative colitis. JPGN 37 (2003) 581-585
28. von Schacky C., Fischer S., and Weber P.C. Long-term effects of dietary marine omega-3 fatty acids upon plasma and cellular lipids, platelet function, and eicosanoid formation in humans. J Clin Invest 76 (1985) 1626-1631
29. Aslan A., and Triadafilopoulos G. Fish oil fatty acid supplementation in active ulcerative colitis. a double-blind, placebo-controlled, crossover study. Am J Gastroenterol 87 (1992) 432-437
30. Barbosa D.S., Cecchini R., El Kadri M.Z., Rodriguez M.A., Burini R.C., and Dichi I. Decreased oxidative stress in patients with ulcerative colitis supplemented with fish oil omega-3 fatty acids. Nutrition 9 (2003) 837-842
31. Belluzzi A., Boschi S., and Brignola C. Polyunsaturated fatty acids and inflammatory bowel disease. Am J Clin Nutr 71 (2000) 339S-342S
32. Belluzzi A., Brignola C., Campieri M., Pera A., Boschi S., and Miglioli M. Effect of an enteric-coated fish-oil preparation on relapses in Crohn's disease. N Engl J Med 334 (1993) 1557-1560
33. Hawthorne A.B., Daneshmend T.K., Hawkey C.J., Belluzzi A., Everitt S.J., Holmes G.K., et al. Treatment of ulcerative colitis with fish oil supplementation. a prospective 12 month randomised controlled trial. Gut 33 (1992) 922-928
34. Lorenz R., Weber P.C., Szimnau P., Heldwein W., Strasser T., and Loeschke K. Supplementation with n-3 fatty acids from fish oil in chronic inflammatory bowel-disease. a randomized placebo-controlled, double-blind, cross-over trial. J Int Med Suppl 225 (1989) 225-232
35. Shoda R., Matsueda K., Yamato S., and Umeda N. Therapeutic efficacy of n-3 polyunsaturated fatty acid in experimental Crohn's disease. J Gastroenterol 30 (1995) 895-1015
36. Stenson W.F., Cort D., Rodgers J., Burakoff R., DeSchryver-Kecskemeti K., Gramlich T.L., et al. Dietary supplementation with fish oil in ulcerative colitis. Ann Intern Med 116 (1992) 609-614
37. Innis S.M., and Elias S.L. Intakes of essential n-6 and n-3 polyunsaturated fatty acids among Canadian pregnant women. Am J Clin Nutr 77 (2003) 473-478
38. Innis S.M., Vaghri Z., and King D.J. N-6 docosapentaenoic acid is not a predictor of low docosahexaenoic acid status in Canadian preschool children. Am J Clin Nutr 80 (2004) 768-773
39. Raper N.R., Cronin F.J., and Exler J. Omega-3 fatty acid content of the US food supply. J Am Coll Nutr 11 (1992) 304-308
40. Institute of Medicine of the National Academy of Sciences. Dietary Reference Intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein, and amino acids (2002), National Academies Press, Washington, D.C.
41. Chow C. Fatty acids in foods and their health implications. 2nd ed. (2000), Marcel Dekker Inc., New York
42. Cavadini C., Siega Riz A.M., and Popkin B.M. US adolescent food intake trends from 1965 to 1996. Arch Dis Child 83 (2000) 18-24
43. Stephen A.M., and Sieker G.M. Trends in individual fat consumption in the U.K. 1900-1985. Br J Nutr 71 (1994) 775-788
44. Stephen A.M., and Wald N.J. Trends in individual consumption of dietary fat in the United States, 1920-1984. Am J Clin Nutr 52 (1990) 457-469
45. Popkin B.M., Siega-Riz A.M., Haines P.S., and Jahns L. Where's the fat? Trends in U.S. diets 1965-1995. Prev Med 32 (2001) 245-254
46. Ekbom A., Helmick, Zack M., and Adami H.O. The epidemiology of inflammatory bowel disease. a large, population-based study in Sweden. Gastroenterology 100 (1991) 350-358
47. Fellows I.W., Freeman J.G., and Holmes G.K.T. Crohn's disease in the city of Derby, 1951-85. Gut 31 (1990) 1262-1265
48. Kyle J. Crohn's disease in the Northeastern and Northern Isles of Scotland. an epidemiological review. Gastroenterology 103 (1992) 392-399
49. Langholz E., Munkholm P., Nielsen O.H., Kreiner S., and Binder V. Incidence and prevalence of ulcerative colitis in Copenhagen County from 1962 to 1987. Scand J Gastroenterol 26 (1991) 1247-1256
50. Lapidus A., Bernell O., Hellers G., Persson P.-G., and Löfberg R. Incidence of Crohn's disease in Stockholm County 1955-1989. Gut 41 (1997) 480-486
51. Lindberg E., and Jarnerot G. The incidence of Crohn's disease is not decreasing in Sweden. Scand J Gastroenterol 26 (1991) 495-500
52. Loftus Jr. E.V., Silverstein M.D., Sandborn W.J., Tremaine W.J., Harmsen W.S., and Zinsmeister A.R. Incidence and prevalence of ulcerative colitis in Olmsted County, Minnesota, 1970-1993. Gastroenterology 112 (1997) A1027
53. Srivastava E.D., Mayberry J.F., Morris T.J., Smith P.M., Williams G.T., Roberts G.M., et al. Incidence of ulcerative colitis in Cardiff over 20 years. 1968-87. Gut 33 (1992) 256-258
54. Thomas G.A., Millar-Jones D., Rhodes J., Roberts G.M., Williams G.T., and Mayberry J.F. Incidence of Crohn's disease in Cardiff over 60 years. 1986-1990 an update. Eur J Gastroenterol Hepatol 7 (1995) 401-405
55. Tysk C., and Jarnerot G. Ulcerative proctocolitis in Orebro, Sweden. A retrospective epidemiologic study, 1963-1987. Scand J Gastroenterol 27 (1992) 945-950
56. Shoda R., Matsueda K., Yamato S., and Umeda N. Epidemiologic analysis of Crohn's disease in Japan. increased dietary intake of n-6 polyunsaturated fatty acids and animal protein relates to the increased incidence of Crohn's disease in Japan. Am J Clin Nutr 63 (1996) 741-745
57. Innis S.M. Perinatal biochemistry and physiology of long chain polyunsaturated fatty acids. J Pediatr 143 (2003) S1-S8
58. Rahm J.J., and Holman R.T. Effect of linoleic acid upon the metabolism of linolenic acid. J Nutr 84 (1964) 15-19
59. Jacobson K., Mundra H., and Innis S.M. Intestinal responsiveness to experimental colitis in young rats is altered by maternal diet. Am J Physiol Gastrointest Liver Physiol 289 (2005) G13-G20
60. Innis S.M. Human milk and formula fatty acids. J Pediatr 120 (1992) S56-S61
61. Innis S.M. Polyunsaturated fatty acids in human milk. an essential role in infant development. Adv Exp Med Biol 554 (2004) 27-43
62. Insull W., Hirsch J., James J., and Ahrens E.H. The fatty acids of human milk. II. Alterations produced by manipulation of calorie balance and exchange of dietary fats. J Clin Invest 38 (1959) 443-450
63. Innis S.M., and King D.J. Trans fatty acids in human milk are inversely associated with concentrations of essential all-cis n-6 and n-3 fatty acids and determine trans, but not n-6 and n-3, fatty acids in plasma lipids of breast-fed infants. Am J Clin Nutr 70 (1999) 383-390
64. Innis S.M. Essential fatty acid transfer and fetal development. Placenta 26 (2005) S70-S75
65. Innis S.M., and de La Presa Owens S. Dietary fatty acid composition in pregnancy alters neurite membrane fatty acids and dopamine in newborn rat brain. J Nutr 131 (2001) 118-122
66. Friesen R., and Innis S.M. Maternal dietary fat alters amniotic fluid and fetal intestinal membrane essential n-6 and n-3 fatty acids in the rat. Am J Physiol Gastrointest Liver Physiol 290 (2006) G505-G510
67. Nieto N., Torres M.I., Rios A., and Gil A. Dietary polyunsaturated fatty acids improve histological and biochemical alterations in rats with experimental ulcerative colitis. J Nutr 132 (2001) 11-19
68. Owen A.J., Peter-Przyborowska B.A., Hoy A.J., and McLennan P.L. Dietary fish oil dose- and time-response effects on cardiac phospholipid fatty acid composition. Lipids 39 (2004) 955-961
69. Graham M.F. Linoleic acid, but not oleic acid, upregulates the production of interleukin-8 by human intestinal smooth muscle cells isolated from patients with Crohn's disease. Clin Nutr 22 (2003) 529-535
70. Fisher M., and Levine P.H. Effects of dietary omega-3 fatty acid supplementation in leukocyte free radical production. World Rev Nutr Diet 66 (1991) 245-249
71. Lands W.E.M., Miller J.F., and Rich S. Influence of dietary fish oils on plasma. Lipid hydroperoxides. Adv Prostagland Thrombox Leukot Res 17 (1987) 876-879
72. Andoh A., Tsujikawa T., Ishizulea I., Araki Y., Sasaki M., Koyama S., et al. N-3 fatty acid-rich diet prevents early response of interleukin-6 elevation in tribitrobenzene sulfonic acid-induced enteritis. Int J Mol Med 12 (2003) 721-725
73. Inui K., Fukuta Y., Ikeda A., Kameda H., Kokubo Y., and Saeto M. The nutritional effect of a-linolenic acid-rich emulsion with total parenteral nutrition in a rat model with inflammatory bowel disease. Ann Nutr Metab 40 (1996) 227-233
74. Shimizu T., Igarashi J., Ohtuka Y., Oguchi S., Kaneoko K., and Yamashiro Y. Effects of n-3 polyunsaturated fatty acids and vitamin E on colonic mucosal leukotriene generation, lipid peroxidation, and microcirculation in rats with experimental colitis. Digestion 63 (2001) 49-54